$BIOA stock has now risen 17% today, according to our price data from Polygon. There has been approximately $20,443,379 of trading volume.
Here is what we see in our data on $BIOA (you can track the company live on Quiver's $BIOA stock page):
$BIOA Insider Trading Activity
$BIOA insiders have traded $BIOA stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $BIOA stock by insiders over the last 6 months:
- PAUL D RUBIN (Chief Medical Officer) has made 0 purchases and 3 sales selling 94,330 shares for an estimated $1,013,399.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BIOA Hedge Fund Activity
We have seen 40 institutional investors add shares of $BIOA stock to their portfolio, and 23 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 270,479 shares (+749.8%) to their portfolio in Q3 2025, for an estimated $1,590,416
- CANTOR FITZGERALD, L. P. removed 200,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,176,000
- ORBIMED ADVISORS LLC removed 131,058 shares (-14.2%) from their portfolio in Q3 2025, for an estimated $770,621
- GEODE CAPITAL MANAGEMENT, LLC added 109,276 shares (+24.1%) to their portfolio in Q3 2025, for an estimated $642,542
- VANGUARD GROUP INC added 93,694 shares (+6.0%) to their portfolio in Q3 2025, for an estimated $550,920
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 71,071 shares (+59.1%) to their portfolio in Q3 2025, for an estimated $417,897
- GOLDMAN SACHS GROUP INC added 64,886 shares (+261.7%) to their portfolio in Q3 2025, for an estimated $381,529
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BIOA Analyst Ratings
Wall Street analysts have issued reports on $BIOA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 10/29/2025
To track analyst ratings and price targets for $BIOA, check out Quiver Quantitative's $BIOA forecast page.
$BIOA Price Targets
Multiple analysts have issued price targets for $BIOA recently. We have seen 2 analysts offer price targets for $BIOA in the last 6 months, with a median target of $13.5.
Here are some recent targets:
- Jeffrey Hung from Morgan Stanley set a target price of $12.0 on 12/08/2025
- Samantha Semenkow from Citigroup set a target price of $15.0 on 10/29/2025
You can track data on $BIOA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
